The Intestinal Microbiota in Colorectal Cancer

Slides:



Advertisements
Similar presentations
Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era  Geoffrey A. Preidis, James.
Advertisements

Obesity and the Microbiota
Volume 40, Issue 1, Pages 1-2 (January 2014)
Clinical Nutrition Experimental
Obesity and Cancer: The Oil that Feeds the Flame
Pathways of liver injury in alcoholic liver disease
Herbert Tilg, Timon E. Adolph  Cell Metabolism 
Inflammation and Colon Cancer
Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era  Geoffrey A. Preidis, James.
Volume 18, Issue 4, Pages (October 2015)
This Gut Ain’t Big Enough for Both of Us. Or Is It
Gut Microbiota: The Link to Your Second Brain
Agustín Albillos, Margaret Lario, Melchor Álvarez-Mon 
Microbial Influences in Inflammatory Bowel Diseases
The Multifaceted Role of the Intestinal Microbiota in Colon Cancer
Fatty Acid-Induced T Cell Loss Greases Liver Carcinogenesis
Interleukin-18: The Bouncer at the Mucosal Bar
Gallstone Disease and Cancer Risk: Finding the Bug in the System
Microbial Modulation of Insulin Sensitivity
ROS Function in Redox Signaling and Oxidative Stress
Volume 44, Issue 6, Pages (June 2016)
Ara Koh, Filipe De Vadder, Petia Kovatcheva-Datchary, Fredrik Bäckhed 
Metabolic control of regulatory T cell development and function
Metabolic Reprogramming of Immune Cells in Cancer Progression
The Intestinal Immune System in Obesity and Insulin Resistance
Ning Li, Sergei I. Grivennikov, Michael Karin  Cancer Cell 
Salmonella Typhimurium Diarrhea Reveals Basic Principles of Enteropathogen Infection and Disease-Promoted DNA Exchange  Sandra Y. Wotzka, Bidong D. Nguyen,
Diet, Metabolites, and “Western-Lifestyle” Inflammatory Diseases
Senescence in Health and Disease
Common TLR5 Mutations Control Cancer Progression
Signaling in Host-Associated Microbial Communities
It’s in the Milk: Feeding the Microbiome to Promote Infant Growth
Pathways in Microbe-Induced Obesity
Pathways of liver injury in alcoholic liver disease
The Origins and Drivers of Insulin Resistance
Gut-Pancreatic Axis AMPlified in Islets of Langerhans
Volume 146, Issue 7, Pages (June 2014)
Bridging immunity and lipid metabolism by gut microbiota
Are pathogenic bacteria just looking for food
Metabolic Instruction of Immunity
Chengcheng Jin, Jorge Henao-Mejia, Richard A. Flavell  Cell Metabolism 
Microbes, Microbiota, and Colon Cancer
Innate sensors of pathogen and stress: Linking inflammation to obesity
Obesity and the Microbiota
Tumor Promotion via Injury- and Death-Induced Inflammation
Maya Saleh, Charles O. Elson  Immunity 
Herbert Tilg, Gökhan S. Hotamisligil  Gastroenterology 
Interleukin-18: The Bouncer at the Mucosal Bar
Role of the Microbiota in Immunity and Inflammation
Translating Inflammatory Bowel Disease Research into Clinical Medicine
Inflammasomes in Intestinal Inflammation and Cancer
Salmonella Typhimurium Diarrhea Reveals Basic Principles of Enteropathogen Infection and Disease-Promoted DNA Exchange  Sandra Y. Wotzka, Bidong D. Nguyen,
Regulation of Stem Cell Aging by Metabolism and Epigenetics
The Fire Within: Microbes Inflame Tumors
Elanor N. Wainwright, Paola Scaffidi  Trends in Cancer 
Homeostasis and Inflammation in the Intestine
Wenjun Ouyang, Anne O’Garra  Immunity 
The Gastrointestinal Tumor Microenvironment
Azucena Ramos, Michael T. Hemann  Cell 
Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System  Thomas Siegmund Postler, Sankar Ghosh  Cell Metabolism 
Azucena Ramos, Michael T. Hemann  Cell 
Beyond Tissue Stiffness and Bioadhesivity: Advanced Biomaterials to Model Tumor Microenvironments and Drug Resistance  Ankur Singh, Ilana Brito, Jan Lammerding 
Inflammasome Complexes: Emerging Mechanisms and Effector Functions
T Cell Dysfunction in Cancer
Kathryn E. Wellen, Craig B. Thompson  Molecular Cell 
Intestinal Ecology in the Metabolic Syndrome
Mechanisms of food allergy
Kathryn E. Wellen, Craig B. Thompson  Molecular Cell 
Volume 44, Issue 6, Pages (June 2016)
Immunity, Inflammation, and Cancer
Presentation transcript:

The Intestinal Microbiota in Colorectal Cancer Herbert Tilg, Timon E. Adolph, Romana R. Gerner, Alexander R. Moschen  Cancer Cell  Volume 33, Issue 6, Pages 954-964 (June 2018) DOI: 10.1016/j.ccell.2018.03.004 Copyright © 2018 Elsevier Inc. Terms and Conditions

Figure 1 Multidimensional Framework of CRC Evolution Malignant degeneration of intestinal epithelial cells (IECs) and progression to CRC involves a complex interplay from various layers of extrinsic and intrinsic factors. Together these influences result in oncogenic mutations in Lgr5+ intestinal stem cells (SCs), in altered β-catenin/Wnt signaling, and in pro-inflammatory programs that drive CRC. (1) Extrinsic, predominantly nutritional factors can directly damage host DNA, modulate the composition and metabolic activity of the gut microbiota, interfere with gut barrier functions, affect IEC metabolism, and influence immune functions. (2) The microbiota influences intestinal tumorigenesis through several mechanisms. Several CRC-associated species such as Fusobacterium nucleatum, colibactin-producing Escherichia coli, and enterotoxigenic Bacteroides fragilis have been implicated in DNA damage and tumor progression. Microbial metabolism of complex carbohydrates, bile acids, and luminal iron, including heme iron, are important for barrier function and immune homeostasis as are bacterial signals integrated by surface and intracellular pattern recognition receptors such as Toll-like receptors, NOD-like receptors, and inflammasomes expressed by various cells types. (3) Chronic inflammation represents an important intrinsic factor that promotes carcinogenesis by inducing DNA damage, and reactive oxygen and nitrogen species, by modulation of IEC polarization and the tumor microenvironment, by activating transcriptional programs such as nuclear factor κB and STAT3 in IECs, and by hampering anti-tumoral immunity. Cancer Cell 2018 33, 954-964DOI: (10.1016/j.ccell.2018.03.004) Copyright © 2018 Elsevier Inc. Terms and Conditions

Figure 2 Microbial Mechanisms Influencing Cancer Development and Progression The tumor-associated luminal environment represents a niche characterized by an impaired barrier function and a cluster of commensal bacteria that have been implicated in tumor initiation and progression. (1) Fusobacterium nucleatum's (Fn) FadA antigen binds E-cadherin on IECs to activate β-catenin. This leads to uncontrolled cell growth, acquisition of a stem cell-like phenotype, loss of cell polarization, and possibly MSI instability. By mechanisms including TLR4 and MyD88, Fn has pro-inflammatory effects on the tumor microenvironment. Furthermore, Fn has been shown to modulate autophagy in IECs by activating regulatory microRNAs. (2) E. coli strains harboring the polyketide synthases (pks) island encoding the genotoxin colibactin are frequently observed in human colorectal tumors. Besides the genotoxic activity of colibactin, cell growth is sustained by cellular senescence associated with the expression of hepatocyte growth factor (HGF). (3) Enterotoxigenic Bacteroides fragilis (ETBF) causes inflammation and tumors in animal models. ETBF induces spermine oxidase (SPO) generating reactive oxygen species (ROS), thereby inducing DNA damage. ETBF is associated with Th17 responses. (4) Certain sulfate-reducing bacteria such as Bilophila wadsworthia or Alistipes spp. produce hydrogen sulfide (H2S) capable of inducing genotoxic insults. Both strains promote inflammation in susceptible animals. Cancer Cell 2018 33, 954-964DOI: (10.1016/j.ccell.2018.03.004) Copyright © 2018 Elsevier Inc. Terms and Conditions

Figure 3 Nutritional Impacts on Intestinal Tumorigenesis (1) Certain nutrient carcinogens including heterocyclic amines, polycyclic aromatic hydrocarbons, and N-nitroso compounds exert direct genotoxic effects. Intestinal homeostasis and an intact gut barrier function ensure spatial segregation and exclusion of luminal threats. Nutrition may be a key modulator of gut microbial composition and barrier function. A diet deprived in microbiota-accessible fiber promotes mucus-degrading species and deprivation of short-chain fatty acids (SCFAs). (2) SCFAs strengthen barrier functions through mechanisms such as G-protein-coupled receptor (Gpr)-mediated sensitization of the IEC inflammasomes and reducing IEC oxygen concentrations and induction of hypoxia-induced factor (HIF). Furthermore, SCFAs exert anti-inflammatory and tolerogenic effects on immune cells. (3) Gut barrier function may be further deteriorated by certain food additives including dietary emulsifiers. (4) Diets enriched in red meat and animal fat promote the overgrowth of pro-inflammatory and pro-tumorigenic species by altering bile acid metabolism. (5) Heme iron further exerts direct cytotoxic and hyperproliferative effects. Cancer Cell 2018 33, 954-964DOI: (10.1016/j.ccell.2018.03.004) Copyright © 2018 Elsevier Inc. Terms and Conditions